[an error occurred while processing this directive]|[an error occurred while processing this directive]
食管鳞癌右胸径路开放术后治疗失败模式与放疗价值评估
刘琳梦1, 梁健2, 韩春1, 王琪1, 王澜1
1河北医科大学第四医院放疗科,石家庄 050011; 2河北省胸科医院医务科,石家庄 050041
Evaluation of the value of postoperative radiotherapy for esophageal squamous cell carcinoma based on the patterns of failure after right thoracotomy
Liu Linmeng1, Liang Jian2, Han Chun1, Wang Qi1, Wang Lan1
1Department of Radiation Oncology, the Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China; 2Medical Department, Hebei Chest Hospital, Shijiazhuang 050041, China
Abstract：The current recommendation for postoperative radiotherapy for esophageal cancer in China is mainly based on the data of incomplete two‐field dissection of the left thoracotomy (category 2B evidence). However, the surgery of esophageal cancer is undergoing a period of transformation, which has gradually transitioned from left thoracotomy to right thoracotomy, and from open surgery to minimally invasive surgery. Compared with incomplete two‐field dissection of left thoracotomy, complete two‐field/cervical thoracic and abdominal three‐field dissection of right thoracotomy could more thoroughly dissect the upper mediastinum and cervical lymph nodes. Hence, theoretically, it yields a lower recurrence rate of regional lymph nodes and prolongs the survival time. However, under the new technical conditions, whether the tumor recurrence pattern and recurrence rate after esophageal cancer surgery will change significantly compared with the past, whether postoperative radiotherapy still has the value of local control and survival benefits, and whether the indications of postoperative radiotherapy need to be adjusted accordingly have not been determined. Based on the above considerations, the changes in surgical methods for esophageal cancer at the current stage, the survival status of right thoracotomy and postoperative patterns of failure were summarized, aiming to evaluate the value of adjuvant radiotherapy under the condition of right thoracotomy.
Liu Linmeng,Liang Jian,Han Chun et al. Evaluation of the value of postoperative radiotherapy for esophageal squamous cell carcinoma based on the patterns of failure after right thoracotomy[J]. Chinese Journal of Radiation Oncology, 2022, 31(12): 1168-1173.
[1] 国家卫生健康委员会.食管癌诊疗规范(2018年版)[J].中华消化病与影像杂志(电子版), 2019,9(4):158‐192. DOI: 10.3877/cma.j.issn.2095-2015.2019.04.005. National Health Commission of the People's Republic of China. Chinese guidelines for diagnosis and treatment of esophageal carcinoma (2018 version)[J]. Chin J Digest Med Imageol (Electronic Edition), 2019, 9(4):158‐192. DOI: 10.3877/cma.j.issn.2095-2015.2019.04.005. [2] Xiao ZF, Yang ZY, Liang J, et al.Value of radiotherapy after radical surgery for esophageal carcinoma: a report of 495 patients[J]. Ann Thorac Surg, 2003,75(2):331-336. DOI: 10.1016/s0003-4975(02)04401-6. [3] Chen J, Pan J, Zheng X, et al.Number and location of positive nodes, postoperative radiotherapy, and survival after esophagectomy with three-field lymph node dissection for thoracic esophageal squamous cell carcinoma[J]. Int J Radiat Oncol Biol Phys, 2012,82(1):475-482. DOI: 10.1016/j.ijrobp.2010.08.037. [4] Yu S, Zhang W, Ni W, et al.A propensity-score matching analysis comparing long-term survival of surgery alone and postoperative treatment for patients in node positive or stage III esophageal squamous cell carcinoma after R0 esophagectomy[J]. Radiother Oncol, 2019,140:159-166. DOI: 10.1016/j.radonc.2019.06.020. [5] Schreiber D, Rineer J, Vongtama D, et al.Impact of postoperative radiation after esophagectomy for esophageal cancer[J]. J Thorac Oncol, 2010,5(2):244-250. DOI: 10.1097/JTO.0b013e3181c5e34f. [6] Kang J, Chang JY, Sun X, et al.Role of postoperative concurrent chemoradiotherapy for esophageal carcinoma: a meta-analysis of 2165 patients[J]. J Cancer, 2018,9(3):584-593. DOI: 10.7150/jca.20940. [7] 中国医师协会放射肿瘤治疗医师分会, 中华医学会放射肿瘤治疗学分会, 中国抗癌协会肿瘤放射治疗专业委员会.中国食管癌放射治疗指南(2021年版)[J].国际肿瘤学杂志, 2022,49(1):12‐25. DOI: 10.3760/cma.j.cn371439- 20211021- 00002. Chinese Medical Doctor Association Radiation Oncology Physicians Branch, China Society for Radiation Oncology, Chinese Association of Radiation Therapy. Chinese guidelines for radiotherapy of esophageal cancer (2021 edition)[J]. J Int Oncol, 2022,49(1):12‐25. DOI: 10.3760/cma.j.cn371439- 20211021-00002. [8] 杨丁, 毛友生. 食管癌手术入路和淋巴结清扫范围的选择[J].中华胃肠外科杂志,2016,19(9):1069-1072. DOI: 10.3760/cma.j.issn.1671-0274.2016.09.027. Yang D, Mao YS.Selection of surgical approaches and lymph node dissection in the esophageal cancer patients[J]. Chin J Gastrointest Surg, 2016,19(9):1069-1072. DOI: 10.3760/cma.j.issn.1671-0274.2016.09.027. [9] Li B, Xiang J, Zhang Y, et al.Comparison of Ivor-Lewis vs Sweet esophagectomy for esophageal squamous cell carcinoma: a randomized clinical trial[J]. JAMA Surg, 2015,150(4):292-298. DOI: 10.1001/jamasurg.2014.2877. [10] Li B, Hu H, Zhang Y, et al.Extended right thoracic approach compared with limited left thoracic approach for patients with middle and lower esophageal squamous cell carcinoma: three-year survival of a prospective, randomized, open-label trial[J]. Ann Surg, 2018,267(5):826-832. DOI: 10.1097/SLA.0000000000002280. [11] 傅世杰, 方文涛, 茅腾, 等. 经不同手术径路治疗胸中下段食管鳞癌的比较研究[J].中华胃肠外科杂志,2012,15(4):373-376. DOI: 10.3760/cma.j.issn.1671-0274.2012.04.019. Fu SJ, Fang WT, Mao T, et al.Comparison of surgical outcomes after different surgical approach for middle or lower thoracic esophageal squamous cancer[J]. Chin J Gastrointest Surg, 2012,15(4):373-376. DOI: 10.3760/cma.j.issn.1671-0274. 2012. 04.019. [12] Luo KJ, Fu JH, Hu Y, et al.[Efficacy of surgical resection of left and right transthoracic approaches for middle thoracic esophageal squamous cell carcinoma][J]. Ai Zheng, 2009,28(12):1260-1264. DOI: 10.5732/cjc.008.10660. [13] 冒志明, 顾晓华, 李昌炎, 等. Ivor‐Lewis经胸颈部机械吻合术治疗中段食管癌的前瞻性研究[J].中华消化外科杂志, 2013,12(10):754‐758. DOI: 10.3760/cma.j.issn.1673-9752. 2013.10.007. Mao ZM, Gu XH, Li CY, et al. Ivor‐Lewis stapled cervical esophagogastrostomy via thorax for middle esophageal carcinoma:a prospective cohort study[J]. Chin J Dig Surg, 2013,12(10):754‐758. DOI: 10.3760/cma.j.issn.1673-9752. 2013.10.007. [14] 赵献军, 付升旗, 刘恒兴, 等. 食管中上段癌左右侧开胸两种手术径路疗效的比较[J].中国肿瘤临床与康复,2016,23(1):25-29. DOI: 10.13455/j.cnki.cjcor.2016.01.07. Zhao XJ, Fu SQ, Liu HX, et al.Comparison of therapeutic efficacy of two kinds of surgical treatment for esophageal carcinoma with left and right thoracotomy[J]. Chin J Clin Oncol Rehabil, 2016,23(1):25-29. DOI: 10.13455/j.cnki.cjcor.2016. 01.07. [15] 邓汉宇, 王志强, 陈龙奇. 食管癌手术的热点研究进展[J].中国胸心血管外科临床杂志, 2017,24(3):233-238. DOI: 10.7507/1007-4848.201608014. Deng HY, Wang ZQ, Chen LQ.Recent advancement of researches on surgery for esophageal cancer[J]. Chin J Clin Thorac Cardiovasc Surg, 2017,24(3):233-238. DOI: 10.7507/1007-4848.201608014. [16] 徐克平, 臧豹.食管癌外科手术现状与进展[J].实用老年医学, 2016,30(2):100‐104. DOI: 10.3969/j.issn.1003-9198. 2016.02.005. Xu KP, Zang B. Surgical status and progress of oesophageal cancer[J]. Pract Geriatr, 2016,30(2):100‐104. DOI: 10.3969/j.issn.1003-9198.2016.02.005. [17] 朱琨, 周灿, 党诚学, 等.低位食管癌Ivor‐Lewis与Sweet径路根治术的临床评价[J].中华肿瘤防治杂志,2011,18(22):1802‐1804. DOI:10.16073/j.cnki.cjcpt.2011.22.018. Zhu K, Zhou C, Dang CX, et al. Clinical evaluation of Ivor‐Lewis'‐and Sweet'‐esophagectomy for lower thoracic esophageal carcinomas[J]. Chin J Cancer Prev Treat, 2011,18(22):1802‐1804. DOI:10.16073/j.cnki.cjcpt.2011.22.018. [18] 陆国庆, 李刚, 居来提·艾尼瓦尔, 等. Ivor‐Lewis与左胸一切口治疗食管中下段癌的近期疗效[J].世界华人消化杂志, 2013,21(33):3710‐3714. DOI: 10.11569/wcjd.v21.i33.3710. Lu GQ, Li G, Julaiti Ainiwaer·, et al. Ivor‐Lewis esophagectomy versus one‐incision esophagectomy via the left thoracic approach in the treatment of middle and lower thoracic esophageal carcinoma[J] World Chin J Digestol, 2013,21(33):3710‐3714. DOI: 10.11569/wcjd.v21.i33.3710. [19] 张鸿, 汪健, 王文辰, 等. 食管癌Ivor-Lewis术式与Sweet术式比较研究的Meta分析[J].中华胃肠外科杂志,2014,(9):892-897. DOI: 10.3760/cma.j.issn.1671-0274.2014.09.012. Zhang H, Wang J, Wang WC, et al.A meta-analysis of esophagectomy:the comparative study of Ivor-Lewis operation and Sweet operation[J]. Chin J Gastrointest Surg, 2014,(9):892-897. DOI: 10.3760/cma.j.issn.1671-0274.2014.09.012. [20] 毛友生, 赫捷, 程贵余. 我国食管癌外科治疗的现状与未来对策[J].中华肿瘤杂志,2010,32(6):401-404. DOI: 10.3760/cma.j.issn.0253-3766.2010.06.001. Mao YS, He J, Cheng GY.Current status of surgical management of esophageal cancer in China and the future strategy[J]. Chin J Oncol, 2010,32(6):401-404. DOI: 10.3760/cma.j.issn.0253-3766.2010.06.001. [21] 潘文标, 项杨威, 谷志涛, 等. 病理N0期胸段食管鳞癌患者术后复发转移相关因素[J].中华胃肠外科杂志,2017,20(9):1045‐1049. DOI: 10.3760/cma.j.issn.1671-0274.2017.09.018. Pan WB, Xiang YW, Gu ZT, et al. Associated factors of postoperative relapse and metastasis in pT1bN0M0‐pT4aN0M0 thoracic esophageal squamous cell carcinoma[J]. Chin J Gastrointest Surg, 2017,20(9):1045‐1049. DOI: 10.3760/cma.j.issn.1671-0274.2017.09.018. [22] Guo XF, Mao T, Gu ZT, et al.Clinical study on postoperative recurrence in patients with pN0 esophageal squamous cell carcinoma[J]. J Cardiothorac Surg, 2014,9:150. DOI: 10.1186/s13019-014-0150-4. [23] 许建华, 叶凯, 许双塔, 等.食管癌三野淋巴结清扫术术后复发特点及相关因素分析[J].福建医科大学学报,2011,45(4):270‐273,286. DOI: 10.3969/j.issn.1672-4194.2011.04.011. Xu JH, Ye K, Xu ST, et al. Recurrence patterns after extended radical esophagectomy with three‐field dissection for the esophagus carcinoma and its risk factors anylysis[J]. J Fujian Med Univ, 2011, 45(4):270‐273,286. DOI: 10.3969/j.issn.1672-4194.2011.04.011. [24] Chen G, Wang Z, Liu XY, et al.Recurrence pattern of squamous cell carcinoma in the middle thoracic esophagus after modified Ivor-Lewis esophagectomy[J]. World J Surg, 2007,31(5):1107-1114. DOI: 10.1007/s00268-006-0551-1. [25] Chen J, Pan J, Liu J, et al.Postoperative radiation therapy with or without concurrent chemotherapy for node-positive thoracic esophageal squamous cell carcinoma[J]. Int J Radiat Oncol Biol Phys, 2013,86(4):671-677. DOI: 10.1016/j.ijrobp. 2013.03.026. [26] Nakagawa S, Kanda T, Kosugi S, et al.Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy[J]. J Am Coll Surg, 2004,198(2):205-211. DOI: 10.1016/j.jamcollsurg.2003.10.005. [27] Bhansali MS, Fujita H, Kakegawa T, et al.Pattern of recurrence after extended radical esophagectomy with three-field lymph node dissection for squamous cell carcinoma in the thoracic esophagus[J]. World J Surg, 1997,21(3):275-281. DOI: 10.1007/s002689900228. [28] Jang HJ, Lee HS, Kim MS, et al.Patterns of lymph node metastasis and survival for upper esophageal squamous cell carcinoma[J]. Ann Thorac Surg, 2011,92(3):1091-1097. DOI: 10.1016/j.athoracsur.2011.03.093. [29] Tachibana M, Kinugasa S, Yoshimura H, et al.Clinical outcomes of extended esophagectomy with three-field lymph node dissection for esophageal squamous cell carcinoma[J]. Am J Surg, 2005,189(1):98-109. DOI: 10.1016/j.amjsurg.2004. 10.001. [30] Natsugoe S, Matsumoto M, Okumura H, et al.Clinical course and outcome after esophagectomy with three-field lymphadenectomy in esophageal cancer[J]. Langenbecks Arch Surg, 2010,395(4):341-346. DOI: 10.1007/s00423-010- 0592-7. [31] Miyata H, Yamasaki M, Kurokawa Y, et al.Survival factors in patients with recurrence after curative resection of esophageal squamous cell carcinomas[J]. Ann Surg Oncol, 2011,18(12):3353-3361. DOI: 10.1245/s10434-011-1747-7. [32] 孔祥泉, 陈俊强, 朱坤寿, 等. N0期食管鳞癌三野根治术后放疗价值的临床研究[J].实用临床医药杂志,2009,13(21):12-15. DOI: 10.3969/j.issn.1672-2353.2009.21.004. Kong XQ, Chen JQ, Zhu KS, et al.A Clinical study on the value of postoperative radiotherapy after three-field lymphadenectomy in N0 esophageal squamous cell carcinoma[J]. J Clin Med Pract, 2009,13(21):12-15. DOI: 10.3969/j.issn.1672-2353.2009.21.004.
2022, Vol. 31 
